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BACKGROUND: Brucea javanica extract has been reported to have anti-proliferative and cell death induction activities. B. javanica extract was 
reported to induce apoptosis through caspase cascade. Most 
of investigated B. javanica extracts were derived from 
seeds and fruits, or commercially available oil emulsion. 
Therefore we conducted a study on B. javanica leaf extract 
(BJLE) in oral cancer cells.
METHODS: B. javanica leaves were collected, identified, 
minced, dried, extracted with distilled ethanol at room 
temperature for 24 hours, filtered and evaporated. Resulted 
BJLE was stored at 4°C. Human oral squamous cell 
carcinoma (HSC)-2 cells were fasted for 12 hours and 
treated with BJLE in various concentrations for 24 hours. 
Cells were then quantified with 3-(4,5-dimethylthiazol-
2-yl)-2,5-Diphenyltetrazolium bromide (MTT) assay, 
Abstract demonstrated with 4',6'-diamidino-2-phenylindole (DAPI) 
staining. To find out mitochondrial membrane permeability 
(MMP), mitochondrial membrane potential (ΔΨM) was 
analyzed.
RESULTS: BJLE reduced percentage of viable HSC-2 
cells in a concentration dependent manner. BJLE induced 
apoptosis in HSC-2 cells. With treatment of 50 μg/ml BJLE, 
fragmented nuclei were seen. ΔΨM of HSC-2 cells treated 
with 50 μg/ml BJLE were shifted to the left, meaning that 
BJLE induced reduction of ΔΨM and attenuation of MMP.
CONCLUSION: Our results suggested that BJLE could 
induce apoptosis by attenuating MMP.
KEYWORDS: Brucea javanica, leaf, apoptosis, HSC-2, 
MTT, DAPI, mitochondria, permeability
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Introduction
Brucea javanica (L.) Merr. is an evergreen shrub belonging 
to Simaroubaceae family.(1) The seeds of B. javanica, named 
as Ya-dan-zi in traditional Chinese medicine, are listed in 
Chinese Pharmacopoeia for the treatment of dysentery, 
malaria, warts and corns.(1,2) B. javanica oil emulsion 
formulation has already been developed as commercially 
available drug for anti-tumor clinical applications in China, 
and its clinical indications include lung cancer, prostate 
cancer, and gastrointestinal cancer.(3-7) 
 B. javanica extract has been reported to have anti-
proliferative and cell death induction activities.(8-16) 
There were numerous cancer lines have been tested with 
B. javanica extract, including breast cancer cell lines, such 
as MCF-7 (8-10), HTB126 (9) and MDA-MB231 (11); 
cervical cancer cell lines, such as CaSki (9), C33A (9) and 
HeLa (9); pancreatic cancer cell lines, such as PANC-1 
(12,13), SW1990 (12,13), CAPAN-1 (12,13) and CAPAN-2 
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(14); non-small cell lung cancer cell line, such as A549 
(8,11); prostate cancer cell line, such as LNCaP (9); hepatic 
cancer cell line, such as Hep3B (11); oesophageal cancer 
cell line, such as SLMT-1 (11); bladder cancer cell line, such 
as T24 (15); colon cancer cell line, such as HCT116 (16); 
oral cancer cell lines, such as KB (17) and ORL-48 (17). All 
reports showed that B. javanica extract was cytotoxic for 
cancer cell lines.(8-17)
 B. javanica extract was shown to have several 
mechanisms in inducing cell death.(9,11-15) Apoptosis 
induction by B. javanica extract was reported, in both 
p53-dependent and -independent pathways.(9) B. javanica 
extract was also reported to induce apoptosis through caspase 
cascade.(11-15) The activated caspases were correlated with 
p38 mitogen-activated protein kinases (MAPK) (13), B cell 
lymphoma 2 (BCL2) (14), Cyclooxygenase 2 (COX-2) (15) 
and nuclear factor κB (NFκB) (15).
 Most of investigated B. javanica extracts were 
derived from seeds and fruits, or commercially available oil 
emulsion.(8,9,11-16) However, other parts of B. javanica 
are also resourceful, like leaves, twigs, fruits and stems.(1) 
However, these parts were not well investigated, only one 
report showing active compounds of B. javanica extract 
derived from twigs, leaves and and inflorescence.(10) 
Therefore we conducted a study on B. javanica leaf extract 
(BJLE). We hypothesized that BJLE have a potential in 
apoptosis induction in oral cancer cells.
Plant Extraction
B. javanica leaves were collected from West Kutai, East 
Borneo. The leaves were identified and extracted in 
Mulawarman University. Briefly, the leaves were minced 
and dried at room temperature. The dried material was 
extracted with distilled ethanol at room temperature for 24 
hours, filtered and then evaporated using rotatory evaporator 
to produce crude ethanol extract of B. javanica. Resulted 
BJLE was stored at 4°C. 
Cell Culture
Human oral squamous cell carcinoma (HSC)-2 cells were 
cultured in Dulbecco’s Modified Eagle’s Medium  (DMEM) 
with high glucose (Sigma Aldrich, St. Louis, MO, USA), 
supplemented with 10% fetal bovine serum (FBS) and 1% 
penicillin-streptomycin. HSC-2 cells were incubated in a 
humidified incubator with 5% CO2, 37°C.
Methods
Cell Viability
Cell viability was performed using 3-(4,5-dimethylthiazol-
2-yl)-2,5-Diphenyltetrazolium bromide (MTT) assay 
(Sigma) as described previously.(18,19) The MTT assay 
provides a quantitative measurement of viable HSC-2 cells 
by determining the amount of formazan crystals produced by 
metabolically active cells. Briefly, 1x104 cells were seeded 
into each well of 96-well plates in medium containing active 
agent, hydrogen peroxide (H2O2) or medium merely. Cells 
were incubated for 24 hours. Ten μl of 5 mg/ml MTT in 
phosphate buffer saline (PBS) was added to each well. The 
plate was then incubated for 4 hours, and then the medium 
was discarded and formazan crystals were dissolved in 100 
μl of 0.1N HCl. The absorbance of cells was measured at 
570 nm by a microplate reader.
4',6'-diamidino-2-phenylindole (DAPI) Staining
DAPI staining was performed as described previously.
(20,21) HSC-2 cells were seeded onto coverslips, treated 
with BJLE, and fixed with 50%, 70%, 90%, and 99.5% 
ethanol for 3 minutes. After washed in PBS, the fixed 
HSC-2 cells were treated with 0.1% BSA and 0.1% Triton 
X-100 for 5 minutes. The cells were stained by applying 
1:150 diluted DAPI (Calbiochem, San Diego, CA, USA) 
for 5 minutes. Then, the coverslips were rinsed with PBS, 
mounted with glycerol, and evaluated under fluorescence 
microscope.
Mitochondrial membrane potential (ΔΨM) analysis
ΔΨM was performed as described previously.(20,21) After 
treatment with BJLE, cells were harvested and suspended 
in 250 μl of 20 nM 3,3'-Dihexyloxacarbocyanine Iodide 
(DiOC6) in PBS and incubated in an incubator for 15 
minutes. ΔΨM was measured using a FACSCanto II flow 
cytometer (Becton Dickinson, Franklin Lakes, NJ, USA).
BJLE reduced percentage of viable HSC-2 cells
With treatment of 0.0014% H2O2 for 24 hours, percentage 
of viable HSC-2 cells were only 10.8 (Figure 1). Meanwhile 
with treatment of dimethyl sulfoxide (DMSO), there were 
78% viable HSC-2 cells. Treatment of BJLE in various 
concentrations (5, 10, 20 and 50 μg/ml), showed that cell 
viability percentage was decreased in BJLE concentration 
dependent manner (85.8%, 82.2%, 69.2%, 49.4%, 
respectively).
Results
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BJLE induced apoptosis in HSC-2 cells
Nuclei of HSC-2 cells were stained with DAPI. Clear bluish 
round nuclei were observed in Figure 2A, showing healthy 
HSC-2 cells population. Meanwhile, with treatment of 
50 μg/ml BJLE, fragmented nuclei were seen, marked by 
green arrow (Figure 2B). Cells with fragmented nuclei were 
apoptotic cells.
BJLE attenuated mitochondrial membrane permeability 
(MMP)
Recorded ΔΨM in untreated HSC-2 cells were labeled by 
DiOC6, observed and marked as green area. ΔΨM of HSC-
2 cells treated with 50 μg/ml BJLE were shifted to the left, 
marked by purple line (Figure 3). This meant BJLE induced 
reduction of ΔΨM and attenuation of MMP.
B. javanica  fruit and seed-derived extracts or commercially 
available oil emulsion have been investigated.(8,9,11-16) 
Currently, we investigated on BJLE as another possible 
potential source for anti-cancer agent. We found that 
treatment of BJLE reduced cell viability percentages in 
BJLE concentration dependent manner. Cell viability 
reduction was caused by apoptosis induction by BJLE, 
demonstrated as fragmented nuclei. Our results were in 
concordance to previous reports showing that B. javanica 
fruit and seed extracts induced apoptosis.(9,11-17)
 B. javanica extract was mostly reported to induce 
apoptosis through caspase cascade.(11-15) B. javanica 
seed extract was shown to activate caspase 3, 8 and 9 (11-
15) These caspases were correlated with mitochondrial 
apoptotic pathway. Therefore, BCL2 family was involved 
in this pathway (13,14), which then lead to attenuation of 
MMP.(14) Our results showed that MMP of HSC-2 cells was 
attenuated by treatment of BJLE. Upon MMP attenuation, 
ΔΨM will be disrupted, then apoptotic factor, such as 
cytochrome-c, will be released to cytoplasm. Other reported 
apoptotic mechanisms were p38-MAPK (13), COX-2 (15), 
and NFκB (15).
 Combined with chemotherapy, B. javanica extract 
could improve quality of life in non-small cell lung cancer 
(NSCLC) patients without any increase in toxicity.(22) B. 
javanica oil emulsion (BJOE) combined with chemotherapy 
could be considered as a safe and effective regimen in 
treating patients with advanced gastric cancer (23) and 
advanced lung adenocarcinoma (24,25). BJOE can improve 
the quality of life and reduce the possibility of some adverse 
effects.(24,25) BJLE could also be important in treating 
cancer patient, therefore further study should be pursued. 
Taken together, our results suggested that BJLE could 
induce apoptosis by attenuating MMP. Further studies are 
necessary to explore BJLE mechanism, safety and efficacy.
Figure 1. BJLE reduced percentage of viable HSC-2 cells. 
After HSC-2 cells were seeded and fasted for 12 hours, BJLE was 
added in various concentrations for 24 hours. Cells were quantified 
using MTT assay as described in "Method". For positive control, 
the cells were treated with 0.0014% H2O2. DMSO was used as 
negative control, since BJLE was suspended in DMSO. Amount of 
DMSO as negative control was equaled to the amount of DMSO 
in 50 μg/ml BJLE.
Figure 2. BJLE reduced percentage of viable HSC-2 cells. After 
HSC-2 cells were seeded and fasted for 12 hours, 50 μg/ml BJLE 
was added for 24 hours (B). For negative control, the cells were 
treated with DMSO merely for 24 hours (A). Cell nuclei were 
demonstrated with DAPI staining as described in "Method". Red 
arrow: necrotic cell; Green arrow: apoptotic cells; White bar: 4 
μm.
!
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Figure 3. BJLE induced MMP. After HSC-2 cells were seeded 
and fasted for 12 hours, 50 μg/ml BJLE was added for 24 hours. 
MMP was measured using ΔΨM analysis as described in "Method".
Discussion
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